RetractedArticleOncoTargets and therapy2018

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.

Renjie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.